← 返回

单细胞测序在免疫细胞及其在癌症免疫治疗中 DNA 损伤修复应用的文献计量学分析

英文原题:Bibliometric analysis of single-cell sequencing researches on immune cells and their application of DNA damage repair in cancer immunotherapy.

查看英文原题

Bibliometric analysis of single-cell sequencing researches on immune cells and their application of DNA damage repair in cancer immunotherapy.

PubMed 2023/01/26(内容时间) Front Oncol Q2 · IF 3.4(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

DNA 损伤修复与免疫治疗的联合似乎为癌症治疗提供了一种新策略。

研究思路结论见上方概要

近几十年来,单细胞测序技术发展迅速,在生命科学的各个领域得到广泛应用,尤其是在免疫细胞检测方面。对2011-2021年期间发表的关于免疫细胞的单细胞测序研究工作进行的文献计量学分析,应为单细胞测序的应用提供新的见解。

我们根据发表时间、文章类型、语言和国家,筛选了1,460篇关于免疫细胞单细胞测序的出版物。结果:美国发表文章最早且数量最多,而中国的研究起步较晚,但发表数量排名第二。T细胞是单细胞测序研究中最常见的免疫细胞,其次是单核巨噬细胞。癌症生物学是单细胞测序免疫细胞研究中最常见的领域。使用γδ T细胞的单细胞测序研究主要集中在癌症生物学和细胞发育领域,并随着时间推移从细胞表面受体转向细胞功能。通过对肿瘤学领域T细胞单细胞测序文章的深入分析,我们的分析发现,免疫治疗和肿瘤微环境是近年来最热门的研究方向。

展开英文摘要原文

INTRODUCTION: In recent decades, single-cell sequencing technology has developed rapidly and used widely in various fields of life sciences, especially for the detection of immune cells. A bibliometric analysis of single-cell sequencing research work on immune cells published during the 2011-2021 period should provide new insight on the use of single-cell sequencing. METHODS: We screened 1,460 publications on single-cell sequencing on immune cells according to the publication date, article type, language, and country. REULTS: The United States published the first and largest number of articles, while China's research started relatively late, but ranked second in the number of publications. T cells were the most commonly studied immune cells by single-cell sequencing, followed by mononuclear macrophages. Cancer biology was the most common field of immune cell research by single-cell sequencing. Single-cell sequencing studies using γδ T cells were mainly in the fields of cancer biology and cell development, and focused over time from cell surface receptor to cell function. Through in-depth analysis of the articles on single-cell sequencing of T cells in the oncology field, our analysis found that immunotherapy and tumor microenvironment were the most popular research directions in recent years. DISCUSSION: The combination of DNA damage repair and immunotherapy seems to provide a new strategy for cancer therapy.

论文信息

作者
Zhao Y、Xiao Y、Hu Z、Wang J、Xu Z、Mo Y、Qi G、Chen K
第一作者单位
Department of Hematology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, Guangdong, China.China
通讯作者单位
Department of Anesthesiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.China
期刊
Frontiers in oncology2023
原文标识
PubMed 36776314 · DOI 10.3389/fonc.2023.1067305